Earlier studies from our laboratory showed that breast cancer cells escape TGF-β mediated growth inhibition by overexpressing transmembrane prostate androgen induced (TMEPAI/PMEPA1), a direct target gene of Smad-dependent TGF-β signaling [14, 15, 28]. This evidence concerns the gene TGFB1 and breast carcinoma.